Sentences with phrase «advises pharmaceutical and biotechnology»

With respect to his life sciences practice, Mr. Bauer regularly advises pharmaceutical and biotechnology clients on a range of transactional matters, including complex licensing arrangements, product and intellectual property acquisition agreements, research and development collaborations, commercialization agreements, marketing and co-promotion agreements and supply and distribution arrangements.

Not exact matches

But while insurers stand to save plenty of money if less women got lymphedema after breast cancer, unlike when new cancer drugs hit the market, exercise offers no immediate profit prospects for pharmaceutical or biotechnology companies — and no multi-million dollar advertising campaign advising patients to query their doctors about it.

During her twelve years with the firm, she advised pharmaceutical, biotechnology, and medical device clients on successful product development, business development, and marketing strategies.

With the help of outstanding biotech and pharmaceutical litigation lawyer, we can advise you to avoid these common pitfalls with biotechnology inventions.

With a bioscience - related Ph.D., he has a particular focus on meeting the intellectual property and transactional needs of technology companies, especially in the pharmaceutical and biotechnology industries, and also regularly advises clients in a variety of other industries, such as media, information technology and financial services.

Mr. Novajosky advises executives of privately - held and publicly - traded companies in the software, IT, pharmaceutical, and biotechnology industries.

For many years, Davis Polk has been advising clients — ranging from the world's largest healthcare companies to startups — with a focus on pharmaceuticals, biotechnology, diagnostics, medical devices and healthcare equipment, genetics, and other areas.

We have deep expertise advising medical device, pharmaceutical and biotechnology companies to compliantly get their products onto markets across Europe and on the full breadth of legal services including transactional work, regulatory advice, IP protection and enforcement services and dispute resolution.

Managing partner David Aylen advises foreign entities on their Russian and CIS operations, and Vladislav Ugryumov has notable expertise in the life sciences sector, particularly within pharmaceuticals and biotechnology.